Tocilizumab for Relapsing Polychondritis

This study has been withdrawn prior to enrollment.
(Tocilizumab was licenced in Canada for children, so the study was not necessary)
Sponsor:
Information provided by:
McMaster Children's Hospital
ClinicalTrials.gov Identifier:
NCT01104480
First received: April 13, 2010
Last updated: July 20, 2011
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: May 2012
  Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)